Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Clinical trial NCT02744339 · COMPLETED

Trial details

NCT number: NCT02744339
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Pulmonary Heart Failure With Normal Ejection Fraction

Start date: 2016-03-01
Primary completion: 2020-08-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.